Navigation Links
Medical Breakthrough ... Doctor Discovers 'Penetrating Carrier' That Eradicates Fungus
Date:11/7/2007

Innovative Custom Products, Inc., has obtained exclusive distribution rights to a 'first of its kind' product line, CureCeuticals, invented by Dr. Marc Selner, a nationally renowned Sports Podiatrist; Cure Toenail

Fungus and Cure Athlete's Foot.

MILWAUKEE, Nov. 7 /PRNewswire/ -- Joe Williams, President and Founder of Innovative Custom Products, Inc., announced today that his firm obtained exclusive distribution rights to a "first of its kind" product line, CureCeuticals, invented by Dr. Marc Selner, a nationally renowned Sports Podiatrist. The lead products in the CureCeuticals line are Cure Toenail Fungus and Cure Athlete's Foot. Both products are all-natural, all-organic, allopathic and homeopathic formulations. These cutting edge products are available without prescription and come in a convenient travel size. Williams said a full Skin Care line utilizing Dr. Selner's breakthrough "penetrating carrier technology" is in development and will be ready for distribution under the CureCeuticals brand within the next 12-18 months.

According to Dr. Selner, Cure Toenail Fungus is the only patent pending OTC topical that actually penetrates the nail, kills the fungus, and allows growth of a new, healthy nail. Cure Athlete's Foot unique formulation allows it to work on contact and eliminates most Athlete's Foot, Jock Itch, and Ringworm within 48 hours. Cure Athlete's Foot also relieves the itching, burning, and scaling associated with these conditions immediately upon application. These products have been used for years in doctors' offices to successfully treat and remedy toenail fungus (Onychomycosis) and athlete's foot (Tenia Pedis), respectively, without side effects.

Dr. Selner said that, unlike other products, Cure Toenail Fungus and Cure Athlete's Foot utilize his "Penetrating Carrier Technology" to allow the contained anti-fungal compounds to actually penetrate the nail or the skin and go directly to where the fungus resides and other topicals do not reach. This delivery system is a major breakthrough; no other OTC product even claim to penetrate the nail and reach the nail bed. The only competitive product is a prescription drug that requires doctor visits and blood tests every six weeks because of its known side effects, and could cost as much as $1,400 for comparable results.

Innovative Custom Products, Inc., a Wisconsin corporation in business since 1992, is a manufacturer and distributor of consumer and pharmaceutical products. According to Williams, consumers are driving the demand for organic products and big box retailers are now paying attention. Williams believes the CureCeuticals product line will generate over $20 million in sales within the next couple years. These products are currently sold in independent pharmacies throughout the USA and are expected in national drug chains soon. Negotiations are currently in place to open the European markets and Williams hopes to open the Canadian and Caribbean markets in 2008. To contact Investor Relations or Distribution Services, email us at: contact@icpCorporation.com or telephone us at (414) 358-1802.

To contact Investor Relations or Distribution Services, email us at: contact@icpCorporation.com or telephone us at (414) 358-1802.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Innovative Custom Products, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
Breaking Biology Technology:
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):